Skip to content

SIGA Technologies SIGA Other Commercial Liabilities

Other Commercial Liabilities at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
Opko Health logo
Opko HealthOPK
Septerna, Inc. logo
Septerna, Inc.SEPN
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's other commercial liabilities?
SIGA Technologies (SIGA) reported other commercial liabilities of $6.53M in Q1 2026.
How has SIGA Technologies's other commercial liabilities changed year-over-year?
SIGA Technologies's other commercial liabilities decreased by 59.8% year-over-year, from $16.23M to $6.53M.
What is the long-term trend for SIGA Technologies's other commercial liabilities?
Over 5 years (2020 to 2025), SIGA Technologies's other commercial liabilities has grown at a -4.7% compound annual growth rate (CAGR), from $8.29M to $6.52M.